1)日本癌治療学会,日本胃癌学会,GIST研究会(編):GIST 診療ガイドライン.2010年11月改訂(第2版補訂版).金原出版,2010,pp1-138
2)Demetri GD, von Mehren M, Antonescu CR, et al:NCCN Task Force report:update on the management of patients with gastrointestinal stromal tumors. J Natl Compr Canc Netw 8(Suppl 2):S1-S41, 2010
3)Corless CL, Barnett CM, Heinrich MC:Gastrointestinal stromal tumours:origin and molecular oncology. Nat Rev Cancer 11:865-878, 2011
4)Landi B, Palazzo L:The role of endosonography in submucosal tumours. Best Pract Res Clin Gastroenterol 23:679-701, 2009
5)Sakamoto H, Kitano M, Matsui S, et al:Estimation of malignant potential of GI stromal tumors by contrast-enhanced harmonic EUS. Gastrointest Endosc 73:227-237, 2011
6)Rossi S, Gasparotto D, Toffolatti L, et al:Molecular and clinicopathologic characterization of gastrointestinal stromal tumors(GISTs)of small size. Am J Surg Pathol 34:1480-1491, 2010
7)Takahashi T, Nakajima K, Nishitani A, et al:An enhanced risk-group stratification system for more practical prognostication of clinically malignant gastrointestinal stromal tumors. Int J Clin Oncol 12:369-374, 2007
8)Joensuu H:Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol 39:1411-1419, 2008
9)Joensuu H, Vehtari A, Riihimäki J, et al:Risk of recurrence of gastrointestinal stromal tumour after surgery:an analysis of pooled population-based cohorts. Lancet Oncol 13:265-274, 2012.